<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Surg</journal-id><journal-id journal-id-type="iso-abbrev">Int J Surg</journal-id><journal-id journal-id-type="pmc-domain-id">2035</journal-id><journal-id journal-id-type="pmc-domain">lwwopen</journal-id><journal-id journal-id-type="publisher-id">JS9</journal-id><journal-title-group><journal-title>International Journal of Surgery (London, England)</journal-title></journal-title-group><issn pub-type="ppub">1743-9191</issn><issn pub-type="epub">1743-9159</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Lippincott Open Access</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12430944</article-id><article-id pub-id-type="pmcid-ver">PMC12430944.1</article-id><article-id pub-id-type="pmcaid">12430944</article-id><article-id pub-id-type="pmcaiid">12430944</article-id><article-id pub-id-type="pmid">40576187</article-id><article-id pub-id-type="doi">10.1097/JS9.0000000000002759</article-id><article-id pub-id-type="publisher-id">IJS-D-25-02714</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Correspondence</subject></subj-group></article-categories><title-group><article-title>Comments to the Editor: opinions on &#8220;Causal effects of primary biliary cholangitis on irritable bowel syndrome: a Mendelian randomization study&#8221;</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Zhao</surname><given-names initials="P">Ping</given-names></name><degrees>MD</degrees><email>767687941@qq.com</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Han</surname><given-names initials="Q">Qiuwan</given-names></name><degrees>MD</degrees><email>Hanqiuwan0326@163.com</email><xref rid="aff1" ref-type="aff">
<sup>a</sup>
</xref><xref rid="COR0001" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Qiu</surname><given-names initials="X">Xu</given-names></name><degrees>PhD</degrees><email>19858874289@163.com</email><xref rid="aff2" ref-type="aff">
<sup>b</sup>
</xref><xref rid="COR0001" ref-type="corresp">*</xref></contrib><aff id="aff1"><label>a</label>Department of Anesthesiology, Hangzhou Xiaoshan District Orthopedics Hospital of Traditional Chinese Medicine, Hangzhou, Zhejiang, China</aff><aff id="aff2"><label>b</label>The Fourth Clinical School of Medicine, Zhejiang Chinese Medical University, Hangzhou, China</aff></contrib-group><author-notes><corresp id="COR0001"><label>*</label>Corresponding authors. Address: Department of Anesthesiology, Hangzhou Xiaoshan District Orthopedics Hospital of Traditional Chinese medicine, No. 79, Jinxiu Road, Dai Village Town, Xiaoshan District, Zhejiang 311261, China. Tel.: +86 18768484918. E-mail: <email>hanqiuwan@163.com</email> (Q. Han); The Fourth Clinical School of Medicine, Zhejiang Chinese Medical University, No. 79, Jinxiu Road, Dai Village Town, Xiaoshan District, Hangzhou 310053, China. Tel.: +86 19858874289. E-mail: <email>19858874289@163.com</email> (X. Qiu).</corresp></author-notes><pub-date pub-type="collection"><month>9</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>27</day><month>6</month><year>2025</year></pub-date><volume>111</volume><issue>9</issue><issue-id pub-id-type="pmc-issue-id">496813</issue-id><fpage>6588</fpage><lpage>6589</lpage><history><date date-type="received"><day>02</day><month>6</month><year>2025</year></date><date date-type="accepted"><day>03</day><month>6</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>12</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>13</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-13 11:25:14.803"><day>13</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 The Author(s). Published by Wolters Kluwer Health, Inc.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbysalicense">https://creativecommons.org/licenses/by-sa/4.0/</ali:license_ref><license-p>This is an open access article distributed under the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons Attribution-ShareAlike License 4.0</ext-link>, which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="js9-111-6588.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="js9-111-6588.pdf"/><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p><italic toggle="yes">Dear Editor</italic>,</p><p>The use of artificial intelligence (AI) in research and literature is increasing, but we still need to exercise moderation in its application<sup>[<xref rid="R1" ref-type="bibr">1</xref>]</sup>. Recently, I read a study, this study employs two-sample Mendelian randomization (MR) techniques for the first time to explore the potential causal relationship between primary biliary cholangitis (PBC) and irritable bowel syndrome (IBS), a topic of significant clinical relevance. The research design strictly adheres to the three core assumptions of MR and includes comprehensive sensitivity analyses, such as MR-Egger intercept tests, Cochran&#8217;s Q tests, and leave-one-out analyses, which are notable strengths of this article. The findings suggest that PBC may increase the risk of IBS (IVW OR&#160;=&#160;1.010887, P =&#160;0.04136), opening new avenues for investigating the &#8220;gut-liver axis&#8221; mechanism. However, several points could be further refined to enhance the robustness of these conclusions:</p><sec><title>Consideration of confounding factors</title><p>The selected single nucleotide polymorphisms (SNPs) may violate the exclusion restriction assumption due to insufficient consideration of other factors that could lead to IBS, such as anxiety/depression and childhood trauma. Selection Criteria for Instrumental Variables: In this study, only SNP-exposure association strength (p&lt;5&#160;&#215;&#160;10<sup>&#8211;8</sup>) and linkage disequilibrium were considered when selecting instrumental variables (IVs). However, SNPs with direct genetic associations with IBS were not excluded from analysis. For example, some SNPs linked to PBC might directly affect IBS risk through non-PBC pathways like immune regulation or bile acid metabolism, introducing confounding bias. It is recommended that phenotype-wide association studies (PheWAS) be conducted to identify SNPs without direct associations with IBS as IVs. As emphasized by Burgess et al., violations of exclusion restrictions are common sources of bias in MR studies; thus verifying SNP specificity through cross-phenotype databases like GWAS Catalog is essential<sup>[<xref rid="R2" ref-type="bibr">2</xref>]</sup>. Reliability Concerns Regarding IVW Method Results: The reliability of results from IVW methods is questionable, as it only showed weak positive significance (P&#160;=&#160;0.04136), while four other methods, including MR-Egger and weighted median, did not reach significance (P&gt;0.05). This inconsistency indicates that IVW results may be affected by weak instrument bias or residual pleiotropy effects.</p></sec><sec><title>More importantly, no correction for multiple testing was performed in this study</title><p>We applied FDR correction on five reported MR analysis outcomes in this paper&#8212;IVW, MR-Egger, weighted median, simple mode, and weighted mode&#8212;and found that after FDR adjustment the minimum p-value obtained via IVW was P&#8336;d<sub>j</sub>&#160;=&#160;0.2068 (&gt;0.05), indicating that exposure-outcome associations are no longer significant. Bowden et al. (2016) noted that when conclusions across various MR methods are inconsistent; caution should be exercised in interpreting significance from IVW results while correcting for multiple testing is crucial for controlling false-positive rates<sup>[<xref rid="R3" ref-type="bibr">3</xref>]</sup>.</p></sec><sec><title>Exploration of heterogeneity sources and subgroup effects</title><p>While acknowledging limitations regarding GWAS data being confined primarily within European populations, the discussion fails addressing potential impacts arising from genetic backgrounds or environmental factors(such as gender/age).Subgroup analyses or inclusion considering gene-environment interactions would provide valuable insights into these aspects. For instance Kurilshikov et al.&#8217;s (2021) multivariable-MR approach corrected confounders revealing population heterogeneity concerning gut microbiome-disease correlations<sup>[<xref rid="R4" ref-type="bibr">4</xref>]</sup>. Moreover existing literature indicates an association between sex differences influencing incidence rates among individuals diagnosed with IBD where females exhibit markedly higher prevalence than males; unfortunately, this aspect wasn&#8217;t separately discussed which represents an oversight.</p></sec><sec><title>Deepening clinical significance</title><p>Referencing Mars et al.&#8217;s (2020) proposed &#8220;gut-liver-brain axis&#8221; theory can facilitate discussions surrounding how hepatic injury resulting from PBC influences occurrences linked towards development mechanisms underlying IBS cases providing directionality towards future mechanistic investigations<sup>[<xref rid="R5" ref-type="bibr">5</xref>]</sup>. Optimization Of Data Utilization: Integrating multi-source GWAS datasets (e.g.FinnGen) to validate findings will enhance statistical power overall.</p><p>In summary, this research provides preliminary evidence for causal links between PBC and IBS. However, limitations related to selection strategies for instruments used, the absence of corrections during multiple testing, and inconsistencies in methodologies necessitate strengthening the robustness of the conclusions. By incorporating additional verification measures focused on specific SNPs and conducting reverse-MR assessments while addressing multiplicity issues, we can significantly enhance the credibility of this inquiry. This will help clarify the roles played by gut-liver axes in both disease entities and yield precise targets for clinical comorbidity management moving forward.</p></sec></body><back><ack><title>Acknowledgements</title><p>Not applicable.</p></ack><fn-group><fn fn-type="equal"><p>Published online 27 June 2025</p></fn></fn-group><sec><title>Ethical approval</title><p>Not applicable.</p></sec><sec><title>Consent</title><p>Not applicable.</p></sec><sec><title>Sources of funding</title><p>There is no any funding.</p></sec><sec><title>Author contributions</title><p>P.Z. and Q.H: conception and manuscript writing; X.Q. manuscript revising. All authors have edited the published version of the manuscript.</p></sec><sec sec-type="COI-statement"><title>Conflicts of interest disclosure</title><p>There are no conflicts of interest.</p></sec><sec><title>Guarantor</title><p>Xu Qiu.</p></sec><sec><title>Research registration unique identifying number (UIN)</title><p>Not applicable.</p></sec><sec><title>Provenance and peer review</title><p>Not invited.</p></sec><sec sec-type="data-availability"><title>Data availability statement</title><p>Not applicable.</p></sec><ref-list><title>References</title><ref id="R1"><label>[1]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Agha</surname><given-names>RA</given-names></name><name name-style="western"><surname>Mathew</surname><given-names>G</given-names></name><name name-style="western"><surname>Rashid</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Transparency In The reporting of Artificial INtelligence &#8211; the TITAN guideline</article-title>. <source>Prem J Sci</source><year>2025</year>;<volume>10</volume>:<fpage>100082</fpage>.</mixed-citation></ref><ref id="R2"><label>[2]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Abbott</surname><given-names>K</given-names></name><name name-style="western"><surname>Y</surname><given-names>Hoy</given-names></name><name name-style="western"><surname>Erickson</surname><given-names>J</given-names></name></person-group>. <article-title>Automatic health record review to help prioritize gravely ill Social Security disability applicants</article-title>. <source>J Am Med Inform Assoc</source><year>2017</year>;<volume>24</volume>:<fpage>709&#8211;16</fpage>.<pub-id pub-id-type="pmid">28108546</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jamia/ocw159</pub-id><pub-id pub-id-type="pmcid">PMC7651957</pub-id></mixed-citation></ref><ref id="R3"><label>[3]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Upadhyed</surname><given-names>S</given-names></name><name name-style="western"><surname>Jaind</surname><given-names>L</given-names></name><name name-style="western"><surname>Trivediy</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>Neonatal screening and the clinical outcome in children with sickle cell disease in Central India</article-title>. <source>PLoS One</source><year>2016</year>;<volume>11</volume>:<fpage>e0147081</fpage>.<pub-id pub-id-type="pmid">26785407</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0147081</pub-id><pub-id pub-id-type="pmcid">PMC4718540</pub-id></mixed-citation></ref><ref id="R4"><label>[4]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kurilshikov</surname><given-names>A</given-names></name><name name-style="western"><surname>Medina-gomez</surname><given-names>C</given-names></name><name name-style="western"><surname>Bacigalupe</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Large-scale association analyses identify host factors influencing human gut microbiome composition</article-title>. <source>Nat Genet</source><year>2021</year>;<volume>53</volume>:<fpage>156&#8211;65</fpage>.<pub-id pub-id-type="pmid">33462485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41588-020-00763-1</pub-id><pub-id pub-id-type="pmcid">PMC8515199</pub-id></mixed-citation></ref><ref id="R5"><label>[5]</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>W</given-names></name><name name-style="western"><surname>Guan</surname><given-names>W</given-names></name><name name-style="western"><surname>Chen</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China</article-title>. <source>Lancet Oncol</source><year>2020</year>;<volume>21</volume>:<fpage>335&#8211;37</fpage>.<pub-id pub-id-type="pmid">32066541</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1470-2045(20)30096-6</pub-id><pub-id pub-id-type="pmcid">PMC7159000</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>